FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称REBASTINIB
异名/同义词2-PYRIDINECARBOXAMIDE, 4-(4-((((3-(1,1-DIMETHYLETHYL)-1-(6-QUINOLINYL)-1H-PYRAZOL-5-YL)AMINO)CARBONYL)AMINO)-3-FLUOROPHENOXY)-N-METHYL-
4-(4-(((3-TERT-BUTYL-1-(QUINOLIN-6-YL)-1H-PYRAZOL-5-YL)CARBAMOYL(AMINO)-3-FLUOROPHENOXY)-N-METHYLPYRIDIN-2-CARBOXAMIDE
DCC-2036 FREE BASE
DP-1919
N-(3-(1,1-DIMETHYLETHYL)-1-(QUINOLIN-6-YL)-1H-PYRAZOL-5-YL)-N'-(2-FLUORO-4-((2- (METHYLCARBAMOYL)PYRIDIN-4-YL)OXY)PHENYL)UREA
REBASTINIB
REBASTINIB [INN]
REBASTINIB [USAN]
REBASTINIB [WHO-DD]
CAS登记号1020172-07-9
物质唯一标识(Unique Ingredient Identifier)75017Q6I97
分子式C30H28FN7O3
国际化合物标识(International Chemical Identifier,InChI)WVXNSAVVKYZVOE-UHFFFAOYSA-N
SMILESc1(cc(ccn1)Oc2cc(c(cc2)NC(=O)Nc3cc(nn3-c4cc5cccnc5cc4)C(C)(C)C)F)C(=O)NC
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System